Literature DB >> 20387080

The AGEs-RAGE axis and nonalcoholic steatohepatitis: the evidence mounts.

Yusuf Yilmaz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20387080     DOI： 10.1007/s00535-010-0251-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  9 in total

Review 1.  Scavenger receptors that recognize advanced glycation end products.

Authors:  Akira Miyazaki; Hitoshi Nakayama; Seikoh Horiuchi
Journal:  Trends Cardiovasc Med       Date:  2002-08       Impact factor: 6.677

2.  A novel mechanism of action of atorvastatin against cardiovascular risk: a commentary on "decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins".

Authors:  Enzo Emanuele; Diego Geroldi
Journal:  Free Radic Biol Med       Date:  2007-07-19       Impact factor: 7.376

3.  Gene expression in human NAFLD.

Authors:  Dario Greco; Anna Kotronen; Jukka Westerbacka; Oscar Puig; Perttu Arkkila; Tuula Kiviluoto; Saara Laitinen; Maria Kolak; Rachel M Fisher; Anders Hamsten; Petri Auvinen; Hannele Yki-Järvinen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-04-03       Impact factor: 4.052

4.  Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH.

Authors:  Yuki Kimura; Hideyuki Hyogo; Sho-ichi Yamagishi; Masayoshi Takeuchi; Tomokazu Ishitobi; Yoshitaka Nabeshima; Koji Arihiro; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2010-01-30       Impact factor: 7.527

Review 5.  Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings.

Authors:  David Stern; Shi Du Yan; Shi Fang Yan; Ann Marie Schmidt
Journal:  Adv Drug Deliv Rev       Date:  2002-12-07       Impact factor: 15.470

6.  Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins.

Authors:  Francesca Santilli; Loredana Bucciarelli; Davide Noto; Angelo B Cefalù; Valentina Davì; Elisabetta Ferrante; Caterina Pettinella; Maurizio R Averna; Giovanni Ciabattoni; Giovanni Davì
Journal:  Free Radic Biol Med       Date:  2007-07-04       Impact factor: 7.376

Review 7.  Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response.

Authors:  Raphael Clynes; Bernhard Moser; Shi Fang Yan; Ravichandran Ramasamy; Kevan Herold; Ann Marie Schmidt
Journal:  Curr Mol Med       Date:  2007-12       Impact factor: 2.222

8.  Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes.

Authors:  H L Tam; S W M Shiu; Y Wong; W S Chow; D J Betteridge; K C B Tan
Journal:  Atherosclerosis       Date:  2009-08-21       Impact factor: 5.162

Review 9.  Soluble RAGE-modulating drugs: state-of-the-art and future perspectives for targeting vascular inflammation.

Authors:  Niccolò Lanati; Enzo Emanuele; Natascia Brondino; Diego Geroldi
Journal:  Curr Vasc Pharmacol       Date:  2010-01       Impact factor: 2.719
  9 in total
  1 in total

Review 1.  Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.

Authors:  Giovanni Musso; Roberto Gambino; James H Tabibian; Mattias Ekstedt; Stergios Kechagias; Masahide Hamaguchi; Rolf Hultcrantz; Hannes Hagström; Seung Kew Yoon; Phunchai Charatcharoenwitthaya; Jacob George; Francisco Barrera; Svanhildur Hafliðadóttir; Einar Stefan Björnsson; Matthew J Armstrong; Laurence J Hopkins; Xin Gao; Sven Francque; An Verrijken; Yusuf Yilmaz; Keith D Lindor; Michael Charlton; Robin Haring; Markus M Lerch; Rainer Rettig; Henry Völzke; Seungho Ryu; Guolin Li; Linda L Wong; Mariana Machado; Helena Cortez-Pinto; Kohichiroh Yasui; Maurizio Cassader
Journal:  PLoS Med       Date:  2014-07-22       Impact factor: 11.069
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.